Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection

Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection

Data is limited on the immunogenicity of the COVID-19 two-vaccination series among patients with hematologic malignancies and current guidelines do not recommend routine monitoring for post-vaccine antibodies. However, we describe three patients who developed severe or critical COVID-19 infections s...

Full description

Bibliographic Details
Main Authors: Yanina Pasikhova, Austin R. Morrison, Ju Hee Katzman, Misbahuddin Syed
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748211070720

Similar Items

Similar Items